BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 10387398)

  • 1. Influencing drug formulary and contract performance.
    Navarro RP
    Manag Care Interface; 1999 Apr; 12(4):89-91, 96. PubMed ID: 10387398
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare formulary model seen by many as too inclusive.
    Carroll J
    Manag Care; 2004 Nov; 13(11):10, 12. PubMed ID: 15595394
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposal to regulate formularies draws sharp difference of opinion.
    Carlson B
    Manag Care; 2002 Feb; 11(2):34-8. PubMed ID: 11904911
    [No Abstract]   [Full Text] [Related]  

  • 5. Aligning business and IT strategy.
    Kwei R
    Health Manag Technol; 1998 Feb; 19(2):72-4. PubMed ID: 10178858
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacy benefit management as a quality safeguard.
    Giaquinta D
    Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost not the primary factor driving drug coverage.
    Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
    [No Abstract]   [Full Text] [Related]  

  • 8. The money trap. Four pitfalls of contract management system integration and how to avoid them.
    Lippman M; McCoy J
    Healthc Inform; 1998 Sep; 15(9):109-10, 112, 114. PubMed ID: 10185036
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of pharmacoeconomic data in managed care: closing the credibility gap.
    Lewis BE
    Manag Care Interface; 1997 Nov; 10(11):99-103. PubMed ID: 10174761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managed care: what now?
    Crane S
    Radiol Manage; 1998; 20(4):16-8. PubMed ID: 10181468
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of upstream and downstream risk through selective contracting.
    Scammon DL; Fuller DA
    J Ambul Care Mark; 1992; 5(1):209-19. PubMed ID: 10122753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working with PBMs (pharmacy benefit managers).
    Peterson C
    Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477
    [No Abstract]   [Full Text] [Related]  

  • 14. Bad tiered formulary designs yield poor outcomes, high cost.
    Sipkoff M
    Manag Care; 2004 Aug; 13(8):27, 31-2, 34-5. PubMed ID: 15457893
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landing a government contract.
    Nelson DR
    Med Interface; 1996 May; 9(5):62-5. PubMed ID: 10157687
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinventing the PBM (pharmacy benefit manager).
    Marcille JA; Wynn P
    Manag Care; 1997 Apr; 6(4):64-6, 75-8. PubMed ID: 10167003
    [No Abstract]   [Full Text] [Related]  

  • 18. Is care coordination making carve-outs less desirable?
    Sipkoff M
    Manag Care; 2008 Nov; 17(11):18-20, 22-4. PubMed ID: 19051994
    [No Abstract]   [Full Text] [Related]  

  • 19. Injectable drugs: the new frontier in pharmacy management.
    Rodgers JR
    Am J Manag Care; 2003 Jun; Suppl Decision Maker News():5-8. PubMed ID: 12866365
    [No Abstract]   [Full Text] [Related]  

  • 20. Providers must carefully evaluate risk in managed care contracts. A guide for contract negotiators.
    Ballun JE
    QRC Advis; 1998 Apr; 14(6):1-8. PubMed ID: 10177474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.